Regen BioPharma Inc (RGBP)
0.085
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Regen BioPharma Total Assets (Quarterly): 0.1702M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1701M |
| March 31, 2024 | 0.1408M |
| December 31, 2023 | 0.1595M |
| September 30, 2023 | 0.3536M |
| June 30, 2023 | 0.2852M |
| February 28, 2023 | 0.4066M |
| December 31, 2022 | 0.4141M |
| September 30, 2022 | 0.559M |
| June 30, 2022 | 0.6897M |
| March 31, 2022 | 0.6309M |
| December 31, 2021 | 0.7352M |
| September 30, 2021 | 1.212M |
| June 30, 2021 | 1.434M |
| March 31, 2021 | 0.178M |
| December 31, 2020 | 0.1506M |
| September 30, 2020 | 0.1232M |
| June 30, 2020 | 0.0955M |
| March 31, 2020 | 0.0681M |
| December 31, 2019 | 0.041M |
| September 30, 2019 | 0.0991M |
| June 30, 2019 | 0.1143M |
| March 31, 2019 | 0.0439M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.1822M |
| September 30, 2018 | 0.209M |
| June 30, 2018 | 0.5588M |
| March 31, 2018 | 0.7571M |
| December 31, 2017 | 1.149M |
| September 30, 2017 | 0.9442M |
| June 30, 2017 | 0.9656M |
| March 31, 2017 | 0.5985M |
| December 31, 2016 | 0.7067M |
| September 30, 2016 | 0.3194M |
| June 30, 2016 | 0.2506M |
| March 31, 2016 | 0.1929M |
| December 31, 2015 | 0.3182M |
| September 30, 2015 | 0.2205M |
| June 30, 2015 | 0.228M |
| March 31, 2015 | 0.5348M |
| December 31, 2014 | 0.0645M |
| September 30, 2014 | 0.0107M |
| June 30, 2014 | 0.0516M |
| March 31, 2014 | 0.1228M |
| September 30, 2013 | 0.1159M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.041M
Minimum
Dec 2019
1.434M
Maximum
Jun 2021
0.413M
Average
0.2852M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Aethlon Medical Inc | 8.847M |
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.328M |
| Shareholders Equity (Quarterly) | -5.158M |
| Debt to Equity Ratio | -0.1394 |
| Current Ratio | 0.0286 |
| Net Debt Paydown Yield | -5.09% |